Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Reistone Starts Global Trial of JAK1 Inhibitor for Atopic Dermatitis

publication date: May 14, 2021

Shanghai Reistone Biopharma has started a global Phase III clinical trial of its Janus kinase type 1 (JAK1) inhibitor in patients with Atopic Dermatitis. SHR0302 is a novel, oral JAK1 inhibitor that Reistone expects will offer an improved safety and efficacy profile compared to pan-JAK inhibitors by avoiding the hematological side effects of JAK2 inhibition. The company, which focuses on bringing China-sourced novel products for autoimmune/inflammatory conditions to global markets, in-licensed global rights to the candidate in autoimmune diseases from Jiangsu Hengrui Medicine. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here